Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT06566586 is recruiting with primary completion estimated March 2026. No public readout of results found in web searches; all sources confirm ongoing status without efficacy data or interpretation.
Found Apr 6, 2026, 2:58 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed90% confidencemanual-chat-review
Will the results be positive?
ClinicalTrials.gov still lists this study as recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.
Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:32 PM
NO_DECISIONDismissed96% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific efficacy readout is publicly available. The cited listings show NCT06566586 is still recruiting/active and explicitly indicates no results posted, so there is not enough evidence to call the Phase 2 outcome positive or negative.
Found Apr 3, 2026, 4:09 PMReviewed Apr 3, 2026, 4:47 PM
NO_DECISIONDismissed97% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific efficacy readout was found. Public sources still describe NCT06566586 as recruiting/active, and a trial-results mirror shows “No Results Posted.” Sponsor materials also only say Phase II studies for TQB3702 have been initiated, not reported.
Found Apr 1, 2026, 7:15 PMReviewed Apr 1, 2026, 7:15 PM